Related Experiment Video

Updated: Aug 21, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

[Aspirin inhibits proliferation and expression of p44/42 MAPK phosphorylation in vascular endothelial cells]

Hui Liu1, Ping Ouyang, Zhen-hua Liu

  • 1Department of Neurology, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China.

Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA
|September 28, 2004
PubMed
Abstract

Insights

Aspirin significantly inhibits vascular endothelial cell proliferation in a dose-dependent manner. This anti-proliferative effect, linked to reduced p44/p42 MAPK phosphorylation, may explain aspirin's protective role in acute coronary disease.

Area of Science:

  • Cardiovascular Pharmacology
  • Cell Biology
  • Molecular Medicine

Context:

  • Vascular endothelial cells are crucial for blood vessel health.
  • Aspirin is widely used for cardiovascular disease prevention.
  • Understanding aspirin's cellular mechanisms is vital.

Purpose:

  • To investigate aspirin's effect on endothelial cell proliferation in vitro.
  • To examine aspirin's impact on p44/p42 mitogen-activated protein kinase (MAPK) phosphorylation.

Summary:

  • Aspirin significantly inhibited ECV 304 cell proliferation in a dose-dependent manner above 1 mmol/L.
  • Aspirin treatment led to a significant reduction in phosphorylated p44/p42 MAPK protein expression.
  • Results indicate aspirin's anti-proliferative action on endothelial cells.

Impact:

  • Aspirin's ability to decrease endothelial cell proliferation is a key finding.
  • This mechanism may contribute to aspirin's protective effects against acute coronary disease.
  • Provides insight into the cellular basis of aspirin's therapeutic benefits.

More Related Videos

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...